[Prescribing immunosuppressive and immunomodulatory drugs in psoriasis].
| Title: | [Prescribing immunosuppressive and immunomodulatory drugs in psoriasis]. |
|---|---|
| Transliterated Title: | Prescrire les immunosuppresseurs et les immunomodulateurs dans le psoriasis. |
| Authors: | Kemula M; Service de dermatologie 1, hôpital Saint-Louis, 75475 Paris Cedex 10.; Bachelez H |
| Source: | La Revue du praticien [Rev Prat] 2004 Jan 15; Vol. 54 (1), pp. 56-9. |
| Publication Type: | English Abstract; Journal Article; Review |
| Language: | French |
| Journal Info: | Publisher: J.-B. Baillière Country of Publication: France NLM ID: 0404334 Publication Model: Print Cited Medium: Print ISSN: 0035-2640 (Print) Linking ISSN: 00352640 NLM ISO Abbreviation: Rev Prat Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Paris, J.-B. Baillière. |
| MeSH Terms: | Adjuvants, Immunologic/*adverse effects ; Adjuvants, Immunologic/*therapeutic use ; Immunosuppressive Agents/*adverse effects ; Immunosuppressive Agents/*therapeutic use ; Psoriasis/*drug therapy; Psoriasis/immunology ; Humans ; Severity of Illness Index |
| Abstract: | Even though systemic immunomodulating or immunosuppressive therapies have shown efficacy in patients with psoriasis, their usage remains restricted to patients with severe, refractory forms of the disease. Indeed, the risk/benefit balance should be cautiously taken into account before prescribing such drugs. Nevertheless, risks inherent to their usage are limited by a careful knowledge of prescription rules and by a monitoring of side effects. |
| Number of References: | 8 |
| Substance Nomenclature: | 0 (Adjuvants, Immunologic); 0 (Immunosuppressive Agents) |
| Entry Date(s): | Date Created: 20040331 Date Completed: 20040921 Latest Revision: 20061115 |
| Update Code: | 20260130 |
| PMID: | 15049602 |
| Database: | MEDLINE |
English Abstract; Journal Article; Review